Therapeutics: Sphingosine 1-phosphate receptor 2 (S1PR2; S1P2; EDG5)

Cancer

INDICATION: Neuroendocrine tumors

In vitro and mouse studies have identified an S1P2 inhibitor that could help treat

Read the full 165 word article

How to gain access

Continue reading with a
two-week free trial.